KTM co-owner Bajaj Auto signs €566m loan before funding deadline
The co-owner of the KTM AG motorcycle maker has secured a €566 million ($632 million) one-year loan within days of a deadline to fund an insolvency plan at the troubled Austrian company.
The European unit of Bajaj Auto Ltd. agreed to the unsecured loan with JP Morgan Chase & Co., DBS Bank Ltd. and Citigroup Inc., according to a regulatory filing to the BSE. The funds will be used for Bajaj Auto's investments, according to the filing which does not name KTM.
KTM's creditors agreed in February to a 70% haircut as part of a restructuring deal. The company has until May 23 to deposit €544 million with its insolvency administrator and pay out a 30% quota to creditors.Bajaj and Austrian entrepreneur Stefan Pierer co-own Swiss-listed Pierer Mobility, which is the parent of KTM. Citi has been advising the company on securing fresh funds, including additional cash required to resume manufacturing.KTM filed for insolvency last year after struggling to navigate the volatile demand for its motorbikes during the Covid-19 pandemic, which led to excessive inventories. The company has been among the hardest hit amid financial difficulties in Austria's industrial sector, suffering from rising energy and labor costs that risk thousands of jobs.
Representatives for KTM and Bajaj didn't immediately respond to requests for comment outside regular business hours.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Gazette
3 hours ago
- India Gazette
Bone-crushing Russia sanctions bill could crush US trade Politico
Washington risks isolating itself from top world economies, including key European allies, according to the outlet The passage of a new US sanctions package on Russia could disrupt America's relationships with its biggest trade partners and isolate it from the world's leading economies, Politico reported on Saturday. The proposed bill includes a steep 500% tariff on imports from any country that continues to buy oil, gas, uranium, or other key commodities from Moscow. Among those most affected would be India and China, which together account for approximately 70% of Russian energy exports. Several other nations that import Russian energy and uranium could also be subject to the bill's penalties. Imposing 500% tariffs on Chinese-made imports would likely trigger a surge in consumer prices, severely disrupt supply chains, and potentially push US unemployment to levels associated with a recession, Politico noted. The sanctions could be described as targeting the US itself since the country continues to rely on enriched uranium imports from Russia for its nuclear power sector. And it could effectively isolate the US from many of the world's leading economies, including its European allies, the article says. US Senator Rand Paul wrote in the publication Responsible Statecraft that the bill "essentially amounts to an embargo" and could trigger "economic calamity on a scale never before seen in our country." He added that such punitive measures are unlikely to change Moscow's core strategic goals and only further entrench the US in a "failing" foreign policy approach. The sanctions bill was introduced in early April by a bipartisan group of senators led by Republican Senator Lindsey Graham and Democratic Senator Richard Blumenthal. In addition to 500% tariffs, the measure includes secondary sanctions targeting countries that maintain commercial ties with Moscow. Graham recently proposed amendments to exempt countries providing military aid to Ukraine from the tariffs. The change would shield the EU, which continues to import gas from Russia. The senator described the bill as "one of the most draconian sanctions bills ever written" and the sanctions as "bone-crushing." Russia has consistently criticized Western sanctions, calling them illegal, and maintains that they have failed to inflict lasting economic damage. In March, Russian President Vladimir Putin said that a total of 28,595 sanctions had been imposed on Russian companies and individuals in recent years - more than the total number on all other countries combined. According to the president, the West sought to eliminate Russia as a competitor, but its economy has only grown more resilient under pressure. (
The Hindu
3 hours ago
- The Hindu
Infosys gets huge relief on GST as DGGI closes ₹32,400-crore pre-show cause notice
In a major relief for Infosys, the Director General of GST Intelligence has closed pre-show cause notice proceedings against the company for financial years 2018-19 to 2021-22 involving a staggering ₹32,403 crore in GST dues. The latest move effectively ends nearly a year-long GST saga for India's second-largest IT services firm. Mid-last year, the goods and services tax (GST) authorities had slapped ₹32,403 crore notice on Infosys for services availed by the company from its overseas branches for five years starting 2017. The GST demand, in fact, exceeds Infosys's annual profits — Infosys's net profit for full FY25 stood at ₹26,713 crore — and its closure now is bound to come as a significant relief for the tech major. Also Read | After ₹32,000 crore demand to Infosys, government said to mull GST notices to other IT majors The Bengaluru-headquartered company, in a BSE filing, said with the receipt of the latest communication from DGGI "this matter stands closed". 'In continuation to our earlier communications on July 31, 2024, August 1, 2024 and August 3,2024 on GST, this is to inform that the company has today received a communication from the Director General of GST Intelligence (DGGI) closing the pre-show cause notice proceedings for the financial years 2018-19 to 2021-22,' the company said in the filing late Friday (June 6, 2025) evening. Infosys, which competes with the likes of TCS, Wipro and others for global IT contracts, said it had received and responded to a pre-show cause notice issued by DGGI for the period July 2017 to March 2022 on the issue of non-payment of IGST under Reverse Charge Mechanism. 'The GST amount as per the pre-show cause notice for this period was Rs 32,403 crore. The company had on August 3, 2024 received a communication from DGGI closing the pre-show cause notice proceedings for the financial year 2017-2018. With the receipt of today's communication from DGGI, this matter stands closed,' Infosys said. Also Read | Nasscom defends Infosys, says ₹32,000-cr. GST notice shows lack of understanding of industry model In July last year, Infosys had informed that Karnataka State GST authorities issued a pre-show cause notice for payment of GST of ₹32,403 crores for the period July 2017 to March 2022 towards the expenses incurred by overseas branch offices of Infosys Ltd, and added that the company has responded to the pre-show cause notice. 'The company has also received a pre-show cause notice from Director General of GST Intelligence on the same matter and the company is in the process of responding to the same,' the filing of July 2024 had said. All along, Infosys maintained that GST is not applicable on these expenses. 'Additionally, as per a recent circular issued by the Central Board of Indirect Taxes and Customs on the recommendations of the GST Council, services provided by the overseas branches to Indian entity are not subject to GST,' Infosys had argued back in July 2024. The tech firm had asserted GST payments are eligible for credit or refund against export of IT services. 'Infosys has paid all its GST dues and is fully in compliance with the central and state regulations on this matter,' the company had contended. The document sent to Infosys by GST authorities at that point had reportedly said, 'In lieu of receipt of supplies from overseas branch offices, the company has paid consideration to the branch offices in the form of overseas branch expense. Hence, M/s Infosys Ltd, Bengaluru is liable to pay IGST under reverse charge mechanism on supplies received from branches located outside India to the tune of Rs 32,403.46 crores for the period 2017-18 (July 2017 onwards) to 2021-22.' The Directorate General of GST Intelligence in Bengaluru had been of the opinion that Infosys did not pay the Integrated-GST (IGST) on the import of services as a recipient of services. For the just-ended March quarter, Infosys reported an 11.7 per cent decline in consolidated net profit to ₹7,033 crore mainly on account of compensation to employees, and acquisitions during the reported period. The company has guided for a revenue growth of 0% to 3% in constant currency terms in the current fiscal year, citing uncertainty in the environment. For the full FY25, profits saw a marginal increase of 1.8% to ₹26,713 crore; revenues climbed 6.06% to reach ₹1,62,990 crore - exceeding its guidance of 4.5% to 5% for the full FY25.
Time of India
5 hours ago
- Time of India
Ayurvedic & herbal products manufacturers in Indore ramp up production as Covid cases increase
Indore: As Covid-19 cases are witnessing an uptick, manufacturers of Ayurvedic and herbal products in Indore have ramped up their production capacities, anticipating a surge in demand for immunity-boosting products. Usually, summers remain the lean season for immunity booster syrups and tablets, but the resurgence of Covid-19 cases led to a jump in enquiries, prompting many units to prepare for increased production ahead of their usual season. Ayush Nirmata Sangh secretary Ashish Dubey said, "We are anticipating a surge in demand for immunity boosters as cases of Covid-19 again started to increase. Many units started preparations and are gradually increasing production." Another manufacturer owner of a local Ayurvedic firm Ravi Kumar said, "We saw an increase in enquiries for our immunity products. To meet this demand, we are expanding our operations to ensure we can deliver quality products to our customers promptly. Also, monsoon and winters are main demand period of Ayurvedic products when demand rises." Industry insiders noted that if the consumption of these products would not meet their expectations, they would still find a market during the monsoon and winter seasons when the demand for syrups and immunity boosters typically spikes. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo Ayurvedic products produced in Indore are distributed across various states in India, including Delhi, Punjab, Maharashtra, Uttar Pradesh, and Uttarakhand, according to local manufacturers. In response to the heightened demand, many manufacturing units are transitioning to automatic production processes, while others are opting for semi-automatic configurations to enhance efficiency. Indore is home to around 240 Ayurvedic medicine manufacturing units, with the total market size exceeding an impressive Rs 1000 crore, as reported by Ayush Nirmata Sangh.
